Position in OMER
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,067,901
-$1,849,139 QoQ
Shares Held
195,824
-14.1% QoQ
Ownership
0.271%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Jump Financial, LLC holds $252,934,314 across 133 Biotechnology names. OMER ranks #39 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
206,675 | $15,519,225 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
291,488 | $11,726,562 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
507,828 | $11,050,335 | |
| 4 | DAWN |
Day One Biopharmaceuticals, Inc.
|
497,365 | $10,663,505 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
504,143 | $10,561,795 | |
| 6 | LEGN |
Legend Biotech Corp
|
516,633 | $9,345,890 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
155,776 | $9,058,374 | |
| 8 | BNTX |
BioNTech SE
|
79,189 | $7,038,317 |
All Filings in OMER
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,067,901 | 195,824 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,917,040 | 228,000 | Shares | Defined | 2026-02-17 | |
| 2023-03-31 | $84,201 | 18,108 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $38,194 | 16,900 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $344,974 | 57,400 | Shares | Sole | 2022-05-12 | |
| 2021-06-30 | $571,221 | 38,492 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $480,572 | 33,630 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||